InnovAtlasMalaria No More
Research institution

Malaria Elimination Initiative (MEI), UCSF Institute for Global Health Sciences

DiscoverDevelopDeliver

The Malaria Elimination Initiative (MEI) in the UCSF Institute for Global Health Sciences Center for Malaria and Vector-Borne Diseases advances malaria elimination and eradication through research, evidence-based solutions, and global partnerships.

8
Endemic countries
1
U.S. states
7
Products and programs
About

What they do

The Malaria Elimination Initiative (MEI) in the UCSF Institute for Global Health Sciences Center for Malaria and Vector-Borne Diseases advances malaria elimination and eradication through research, evidence-based solutions, and global partnerships.1 Its work includes discovery research, clinical trials, implementation research, development of new tools and decision frameworks, regional collaboration, policy advocacy, and efforts to secure sustainable funding for malaria elimination.1 MEI also helps shape global malaria policy, including through leadership on the Lancet Commission on malaria eradication.1 Its U.S. research activities are based in San Francisco, California, and its work spans the discovery, development, and delivery stages.1

In the United States
Products and programs

In the field and in development

Focal mass drug administration (fMDA) to reduce Plasmodium vivax transmission, a pragmatic cluster randomized controlled trial in Peru (NIH U01AI157962; PI Michelle Hsiang)3,1
Long-term health and socioeconomic impact of interventions targeting low-density malaria infection (LMI) among children in Tanzania (NIH U01AI155315; PI Michelle Hsiang)4,1
Mentoring in clinical trials and patient-oriented research in infectious diseases and global health (NIH K24AI196470; PI Michelle Hsiang)1
Mind the Gap: strengthening malaria vector control and surveillance systems and capacity in Africa (INV-069333; Co-PIs Edward Thomsen and Allison Tatarsky)5,6,1
Optimizing blackfly surveillance and control for river blindness (Gates Foundation INV-104721; PI Edward Thomsen)1
Technical leadership and support for screening and advancing volatile AIs (Innovative Vector Control Consortium; PI Ingrid Chen)7,1
Malaria importation and the role of agriculture in local transmission in Eswatini (MIRA) (NIH R21AI190485; PI Jennifer Smith)8,1
Where they work

Partnerships in 8 endemic countries

Clinical trialsResearchSurveillance and genomicsPrograms and deliveryTraining and capacity
  • Ministry of Health · capacity strengthening and vector surveillance1
  • University of Kinshasa School of Public Health · capacity strengthening and vector surveillance6,1
Eswatini
Africa
  • Ministry of Health · research collaboration (development)1
Ghana
Africa
  • Ghana Health Service · capacity strengthening, vector surveillance, and research collaboration (implementation research)6,1
  • University of Ghana School of Public Health · capacity strengthening, vector surveillance, and research collaboration (implementation research)1
  • Ministry of Health · capacity strengthening and vector surveillance1
  • Eduardo Mondlane University · capacity strengthening and vector surveillance6,1
Nigeria
Africa
  • Ministry of Health · capacity strengthening and vector surveillance1
  • Osun University · capacity strengthening and vector surveillance1
Peru
Latin America
  • Universidad Peruana Cayetano Heredia · research collaboration (clinical trials)3,1
Tanzania
Africa
  • Ifakara Health Institute · research collaboration (discovery, development, and clinical trials)4,1
Uganda
Africa
  • Ministry of Health · capacity strengthening, vector surveillance, and research collaboration (implementation research)1
  • Infectious Diseases Research Collaboration · capacity strengthening, surveillance, and research collaboration (implementation research)6,1
U.S. partners

Who they work with in the United States

Sources

Where this comes from